Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Sorafenib Loaded Pluronic F127-Lithocholic Acid Micelles for Prostate Cancer Therapy: Formulation, Optimization, and in Vitro Evaluation Against Lncap Cells Publisher

Summary: A study found drug-loaded nanomicelles kill cancer cells better with fewer side effects. #CancerResearch #Nanotechnology

Nasehi N1 ; Varshosaz J1 ; Taymouri S1 ; Rostami M2 ; Akbari V3 ; Firoozpour L4
Authors

Source: International Journal of Polymeric Materials and Polymeric Biomaterials Published:2020


Abstract

In present study, sorafenib loaded nanomicelles were prepared with synthesized pluronic F127 - lithocholic acid by film hydration method. The optimized micelles were spherical showing particle size of 319.36 nm, zeta potential of -11.96 mV, encapsulation efficiency of 87.31%, loading efficiency of 14.87% and release efficiency of 30.1%. Sorafenib loaded nanomicelles showed negligible hemolysis activity on RBC, indicating excellent hemocompatibility of pluronic F127 - lithocholic acid. The drug free nanomicelles showed no cytotoxicity against L929 cells by using MTT assay. However, micellar sorafenib showed more anti-proliferation effect on LNCaP and DU145 cells as compared with free sorafenib. © 2019, © 2019 Taylor & Francis Group, LLC.
Other Related Docs